Eric Faulkner
Chief Technology Officer · CNS Pharmaceuticals, Inc.
Individual
- 2026
- Mar 4, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Eric Faulkner files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Faith L. Charles - $34K in CNSP purchases and sales in the last 12 months
- Michal Fisher - $10K in CNSP purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Eric Faulkner?
Eric Faulkner is a corporate insider, tracked as Chief Technology Officer of CNS Pharmaceuticals, Inc. (CNSP). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Eric Faulkner last file a Form 4?
The only primary Form 4 on record is dated 4 March 2026.